Since the recent release of the NIH intramural publication detailing findings from the ME/CFS Inpatient Study, there has been a whirlwind of impassioned commentary. While we harbor mixed sentiments about the paper, we’ve committed professionally to maintaining...
The NIH will host 3 days of meetings focusing on ME/CFS research. The meeting on April 3 is titled, “Thinking the Future: A Workshop for Young Early Career ME/CFS Investigators”. This is followed on April 4–5 with a meeting titled, “Accelerating Research on ME/CFS”. ...
Research tends to neglect ME/CFS and FM – until right now. Precision medicine is the emerging scientific idea that medical treatment can and should be maximally efficient by tailoring medicine and healthcare to individual circumstances. Current research studies,...
Buzz – January 2017: We scoured the Internet to bring you a list of news articles, blogs and research publications we think you’ll find interesting for this month’s What’s the Buzz post. On January 27th, the NIH made two big announcements of federal...
An ME/CS Progress Report Lucinda Bateman, MD, BHC Founder and Medical Director, is actively engaged in ME/CFS and FM thought leadership across the globe. In October she was on the road to take part in and advance the discussions that lead to progress. In a few short...
Lucinda Bateman, MD, is a renowned clinician, researcher, and educator. Her Johns Hopkins University Medical School training instilled an approach to care that she has employed throughout her career - the patient comes first and the unknown or unexplained does not equate to a lack of proper and compassionate care. Since starting her own practice in 2000, she has served on six boards or committees, been the principal investigator for 45 studies, authored/coauthored 40 journal articles, served as adjunct instructor and adjunct assistant professor in the University of Utah Departments of Preventative Medicine, Internal Medicine, and Anesthesiology, and lectured around the world. Bateman served as a clinical expert on the 2015 IOM/NAM committee, contributing her expertise in the development of the clinical diagnostic criteria for ME/CFS, a pivotal and influential moment for all clinicians, researchers, and patients. Medical and scientific collaborations include work with Stanford, Columbia, Cornell, Harvard, CDC, NIH, RECOVER Initiative, Riken, and she is the co-founder of the U.S. ME/CFS Clinician Coalition. In 2015 she expanded her impact by combining her private clinical and research practice with its sister non-profit, OFFER, to create a medical center of excellence, BHC, dedicated to the diagnosis, management, research, and education for the benefit of individuals impacted by msCCD. Her passion for increasing access to informed medical care fuels her focus on medical education today.
Lucinda Bateman, MD, is a renowned clinician, researcher, and educator. Her Johns Hopkins University Medical School training instilled an approach to care that she has employed throughout her career - the patient comes first and the unknown or unexplained does not equate to a lack of proper and compassionate care. Since starting her own practice in 2000, she has served on six boards or committees, been the principal investigator for 45 studies, authored/coauthored 40 journal articles, served as adjunct instructor and adjunct assistant professor in the University of Utah Departments of Preventative Medicine, Internal Medicine, and Anesthesiology, and lectured around the world.
Bateman served as a clinical expert on the 2015 IOM/NAM committee, contributing her expertise in the development of the clinical diagnostic criteria for ME/CFS, a pivotal and influential moment for all clinicians, researchers, and patients. Medical and scientific collaborations include work with Stanford, Columbia, Cornell, Harvard, CDC, NIH, RECOVER Initiative, Riken, and she is the co-founder of the U.S. ME/CFS Clinician Coalition.
In 2015 she expanded her impact by combining her private clinical and research practice with its sister non-profit, OFFER, to create a medical center of excellence, BHC, dedicated to the diagnosis, management, research, and education for the benefit of individuals impacted by msCCD. Her passion for increasing access to informed medical care fuels her focus on medical education today. Read her full bio here.
Many employers use platforms such as United Way, Benevity, Bright Funds, and Community Health Charities (CHC) to support charitable giving. Ask your employer how they support charitable giving and how Bateman Horne Center of Excellence can be included. Bateman Horne Center of Excellence is a 501c3 non-profit organization. EIN #87-0687610
For more information or questions contact us at [email protected]
Please indicate the honoree's name and who (if anyone) we should notify of the gift. To give by check make it payable to Bateman Horne Center and mail to: 24 South 11 East Suite 205, Salt Lake City, Utah 84102 Click here to give online.
Bateman Horne Center Donate
Check-Instructions
Donate Monthly
Contact Angela Linford, Development Officer about how you can include Bateman Horne Center in your will or estate planning.
Gifts of long-term appreciated securities offer you an advantageous way to support Bateman Horne Center and minimize capital gains taxes.
For more information on making a large gift or donating stock please contact Rob Ence, Executive Director, at [email protected]
Lucinda Bateman, MD, is a renowned clinician, researcher, and educator. Her Johns Hopkins University Medical School training instilled an approach to care that she has employed throughout her career - the patient comes first and the unknown or unexplained does not equate to a lack of proper and compassionate care. Since starting her own practice in 2000, she has served on six boards or committees, been the principal investigator for 45 studies, authored/coauthored 40 journal articles, served as adjunct instructor and adjunct assistant professor in the University of Utah Departments of Preventative Medicine, Internal Medicine, and Anesthesiology, and lectured around the world.